Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital-acquired infections and a significant public health concern in the United States. From 1999 to 2005, the estimated number of hospitalizations related to S. aureus increased by 62%, from 294,570 to 477,927, while MRSA-related hospitalizations more than doubled, from 127,036 to 278,203. These findings highlight the growing burden of S. aureus and MRSA infections, emphasizing the need for national disease control strategies. S. aureus is a leading cause of hospital-acquired infections, including lower respiratory tract infections, surgical site infections, and nosocomial bacteremia. Resistance to antimicrobial drugs has evolved over time, with penicillin resistance spreading from hospitals to the community. MRSA, which is now endemic in many US hospitals, long-term care facilities, and communities, has followed a similar pattern of emergence. Community-associated MRSA strains are increasingly spreading into healthcare settings, and MRSA-related infections have become the dominant cause of community-associated S. aureus skin and soft tissue infections. The study used national hospitalization and resistance data to estimate the annual number of S. aureus and MRSA-related hospitalizations and deaths. The estimated number of S. aureus-related deaths increased from 10,800 to 11,406, with MRSA-related deaths rising from 5,500 to 6,639. The study found that the rate of S. aureus-related infections increased by 5% per year in the Northeast, 7% in the Midwest and South, and 8% in the West. MRSA-related infections increased by 9%, 11%, and 12% per year in the Northeast, Midwest, and South, respectively. The West had the lowest incidence but still saw an 18% annual increase. The study also found that the percentage of S. aureus-related hospitalizations resulting in death decreased from 8.4% in 1999 to 6.1% in 2005, and for MRSA-related hospitalizations, it decreased from 8.8% to 6.2%. Despite these decreases, the overall burden of MRSA infections remains significant, with increasing costs for healthcare systems. The study highlights the need for improved infection control measures, antimicrobial stewardship, and public awareness to address the growing problem of MRSA. The findings suggest that community-associated MRSA is spreading more rapidly and is becoming increasingly prevalent in hospitals, complicating efforts to prevent infections in hospitalized patients. The study underscores the importance of national surveillance and research to better understand and control the spread of MRSA and S. aureus infections.Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital-acquired infections and a significant public health concern in the United States. From 1999 to 2005, the estimated number of hospitalizations related to S. aureus increased by 62%, from 294,570 to 477,927, while MRSA-related hospitalizations more than doubled, from 127,036 to 278,203. These findings highlight the growing burden of S. aureus and MRSA infections, emphasizing the need for national disease control strategies. S. aureus is a leading cause of hospital-acquired infections, including lower respiratory tract infections, surgical site infections, and nosocomial bacteremia. Resistance to antimicrobial drugs has evolved over time, with penicillin resistance spreading from hospitals to the community. MRSA, which is now endemic in many US hospitals, long-term care facilities, and communities, has followed a similar pattern of emergence. Community-associated MRSA strains are increasingly spreading into healthcare settings, and MRSA-related infections have become the dominant cause of community-associated S. aureus skin and soft tissue infections. The study used national hospitalization and resistance data to estimate the annual number of S. aureus and MRSA-related hospitalizations and deaths. The estimated number of S. aureus-related deaths increased from 10,800 to 11,406, with MRSA-related deaths rising from 5,500 to 6,639. The study found that the rate of S. aureus-related infections increased by 5% per year in the Northeast, 7% in the Midwest and South, and 8% in the West. MRSA-related infections increased by 9%, 11%, and 12% per year in the Northeast, Midwest, and South, respectively. The West had the lowest incidence but still saw an 18% annual increase. The study also found that the percentage of S. aureus-related hospitalizations resulting in death decreased from 8.4% in 1999 to 6.1% in 2005, and for MRSA-related hospitalizations, it decreased from 8.8% to 6.2%. Despite these decreases, the overall burden of MRSA infections remains significant, with increasing costs for healthcare systems. The study highlights the need for improved infection control measures, antimicrobial stewardship, and public awareness to address the growing problem of MRSA. The findings suggest that community-associated MRSA is spreading more rapidly and is becoming increasingly prevalent in hospitals, complicating efforts to prevent infections in hospitalized patients. The study underscores the importance of national surveillance and research to better understand and control the spread of MRSA and S. aureus infections.